Literature DB >> 16678971

Ca(v)3.1 splice variant expression during neuronal differentiation of Y-79 retinoblastoma cells.

G E Bertolesi1, R Walia Da Silva, C A B Jollimore, C Shi, S Barnes, M E M Kelly.   

Abstract

A decrease in transient-type calcium channel current, Ca(v)3.1 protein and the mRNA encoding these channels has been reported during differentiation of human retinoblastoma cells. In this study, we examined splice variants of Ca(v)3.1 before and after neuronal differentiation of the Y-79 retinoblastoma cell line to investigate the potential contribution of Ca(v)3.1 to Y-79 differentiation. In Ca(v)3.1, alternative splicing induces variations in three cytoplasmic regions, e.g. the link between domains II and III (producing isoforms e+ and e-), the link between domains III and IV (producing isoforms a, b, ac and bc) and the carboxy terminal region (producing isoforms f and d). Our results demonstrate that Ca(v)3.1e was not expressed in either undifferentiated or differentiated retinoblastoma cells. Splice variants Ca(v)3.1ac; Ca(v)3.1bc and Ca(v)3.1b were all identified in undifferentiated retinoblastoma cells, while expression of these variants in differentiated cells was restricted to the Ca(v)3.1bc isoform. The carboxy terminal variant Ca(v)3.1f is expressed independently of the differentiation status of retinoblastoma cells with or without Ca(v)3.1d. Examination of the functional contribution of Ca(v)3.1 protein to Y-79 cell differentiation revealed that in Y-79 cells transfected with Ca(v)3.1 antisense oligodeoxynucleotides, knockdown of Ca(v)3.1 did not alter the time-course of differentiation or neuritogenesis. The changes in Ca(v)3.1 splice variants were not required for the initiation of differentiation but may be associated with tissue-specific expression or localized alterations in Ca(2+) signaling that are essential for establishment of the mature differentiated phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678971     DOI: 10.1016/j.neuroscience.2006.03.067

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.

Authors:  Lisheng Ge; Neil T Hoa; Zechariah Wilson; Gabriel Arismendi-Morillo; Xiao-Tang Kong; Rajeev B Tajhya; Christine Beeton; Martin R Jadus
Journal:  Int Immunopharmacol       Date:  2014-07-12       Impact factor: 4.932

2.  T-type calcium channels as therapeutic targets for treating "giant" retinoblastoma cancer cells.

Authors:  Emilio Carbone
Journal:  Pflugers Arch       Date:  2021-09-07       Impact factor: 3.657

3.  Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels.

Authors:  Sooyun Kim; Segundo Jose Guzman; Dong Hyun Jo; Chang Sik Cho; Jeong Hun Kim
Journal:  Pflugers Arch       Date:  2021-08-15       Impact factor: 4.458

Review 4.  Genetic T-type calcium channelopathies.

Authors:  Norbert Weiss; Gerald W Zamponi
Journal:  J Med Genet       Date:  2019-06-19       Impact factor: 6.318

Review 5.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 6.  Ocular transient receptor potential channel function in health and disease.

Authors:  Peter S Reinach; Stefan Mergler; Yuka Okada; Shizuya Saika
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

7.  RNA-Sequencing of Primary Retinoblastoma Tumors Provides New Insights and Challenges Into Tumor Development.

Authors:  Sailaja V Elchuri; Swetha Rajasekaran; Wayne O Miles
Journal:  Front Genet       Date:  2018-05-17       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.